All In MedTech

Device Trial Radar · NCT05870163

Post-Market Registry for the Evaluation of RefluxStop in GERD Treatment

A Post-market Registry Study to Assess Safety and Performance of RefluxStop™ in the Treatment of Gastroesophageal Reflux Disease (GERD) in General Hospital Practice

Last checked: Nov 19, 2026Latest source record: Apr 1, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

2,500

Planned (sponsor's estimate)

Start

Feb 20, 2023

Primary completion

Dec 1, 2025

Study completion Dec 31, 2029

Sponsor

Lead sponsor
Implantica CE Reflux Ltd.Not on our public-company list
Sponsor type
Industry
First posted
May 23, 2023

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This post-market registry aims to assess safety and performance of RefluxStop™ in the treatment of Gastroesophageal Reflux Disease (GERD) in standard of care procedures.

Conditions

  • Gastroesophageal Reflux Disease (GERD)

Interventions

  • RefluxStop implantationDevice

    Standard surgical technique for implantation RefluxStop, as described in the Itructions for Use

  • Nissen fundoplicationProcedure

    Standard of care Nissen fundoplication surgery

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary safety endpointTime frame: 6 months
  2. Primary performance endpointTime frame: 6 months

Locations

6 sites in 4 countries. Site status is shown where the registry gives one.

  • Klinikum Friedrichshafen GmbH

    Friedrichshafen, Germany · Active not recruiting

  • Ospedale IRCCS Saverio De Bellis

    Bari, Italy · Recruiting

  • Ospedale Buon Consiglio Fatebenefratelli

    Naples, Italy · Recruiting

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.